Skip to main content

Novacyt Inks Supply Contract for Coronavirus Test With UK Health Agency

NEW YORK – Novacyt said Monday it has inked a supply contract with the UK Department of Health and Social Care (DHSC) for a COVID-19 PCR test developed by its Primerdesign molecular diagnostics division in the United Kingdom. 

Under the terms of the agreement, Novacyt will supply its test to the DHSC for an initial term of six months, starting May 4. Vélizy-Villacoublay, France-based Novacyt has initially committed to supply 288,000 tests per week to the DHSC for use in the NHS and has an option to expand the agreement. 

Financial and other terms of the agreement were not disclosed.

The partnership with the DHSC reinforces Novacyt's existing support of the UK government's five-pillar plan to increase testing for COVID-19, the firm said. Novacyt had announced in April that it is collaborating with AstraZeneca, GlaxoSmithKline, and the University of Cambridge to increase SARS-CoV-2 testing in the UK.